Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New research to explore family experiences of long COVID.

Awards & appointments COVID-19

The Nuffield Department of Primary Care Health Sciences is delighted to announce that it has been awarded £557,674 to investigate how families are managing to cope with ‘long covid’ and to understand how best they can be supported

People with learning disabilities “extremely vulnerable” to the effects of COVID-19, finds study

Big data COVID-19

The results, from within the OpenSAFELY platform, are based on electronic health records for more than 17 million people registered with a general practice in England linked to hospital admission and mortality data.

COVID-19 risk prediction tool wins national award

Big data COVID-19

The QCovid®-powered COVID-19 Population Risk Assessment, developed by a cross-organisational team and rolled across NHS England, has won the Florence Nightingale Award for Excellence in Healthcare Data Analytics.

Benefit-to-harm balance of statins for healthy adults "generally favourable", suggests Oxford-led research

Cardiovascular & metabolic DPhil

Statins are associated with a small increased risk of side effects in patients without a history of heart disease, but these effects are mild compared with the potential benefits of treatment in preventing major cardiovascular events, finds a study led by Oxford University researchers.

PRINCIPLE trial 'highly commended' for innovative use of health data

Big data COVID-19 Clinical trials

The PRINCIPLE trial has been highly commended at the Health Data Research UK Awards for the way in which patient data is utilised so participants are contacted about the trial soon after receiving a positive test result.

Ethnic minority children may be disproportionately impacted by COVID-19, suggests analysis

Big data COVID-19 DPhil

There are higher proportions of ethnic minority children in England testing positive for COVID-19 than white children, with Asian children more likely to be admitted to hospital with the illness, finds an observational analysis of 2.6 million healthcare records led by Oxford University researchers.

Celebrating International Clinical Trials Day 2021

COVID-19 Clinical trials

Each year, International Clinical Trials Day recognises the people who conduct clinical trials, giving our community a chance to say thank you for everything they do to improve public health. This year our trials unit staff are sharing what makes them proud to be part of Oxford’s Primary Care Clinical Trials Unit.

New study shows potential link between bodyweight and risk of severe COVID-19, especially for younger adults

Big data COVID-19 QResearch

The first large study to report the effect of bodyweight on risk of worse outcomes from COVID-19 across the full range of body mass index (BMI) is published today in The Lancet Diabetes and Endocrinology journal.

Foods associated with an increased risk of cardiovascular disease and death in middle-age identified

Cardiovascular & metabolic Health behaviours

Two common dietary patterns identified in British adults, which include high intakes of chocolate and confectionary, may be associated with an increased risk of cardiovascular disease and death in middle-age, according to a study published in the open access journal BMC Medicine by Oxford University researchers.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

COVID-19 Clinical trials Infection & acute care

Inhaled budesonide, a common corticosteroid, is the world's first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants. As of today, the treatment is available in UK primary care on a case-by-case basis.

Favipiravir to be investigated as a possible COVID-19 treatment for at-home recovery in the PRINCIPLE trial

COVID-19 Clinical trials Infection & acute care

Could the antiviral favipiravir help transform COVID-19 into an illness that can be successfully treated by general practitioners?

Risk of severe COVID-19 from asthma and other respiratory diseases may be only modestly increased, new analysis suggests

Big data COVID-19 Cardiovascular & metabolic

People with asthma have only a modestly increased risk of developing severe Covid-19 and requiring admission to hospital from the illness, finds an analysis of 8.3 million electronic health care records in England led by University of Oxford researchers.

Five simple steps to effective opportunistic weight loss conversations in family practice

Health behaviours Policy & health systems

Five simple communication changes could enable doctors to have more equitable and effective conversations about weight loss, finds new research from the University of Oxford and Loughborough University. With obesity as one of the few modifiable risk factors for developing severe COVID, the findings are especially important during the current pandemic.

NIHR School for Primary Care Research relaunches with new focus to strengthen whole primary care research sector

Awards & appointments

Oxford University continues its membership of the national school, while the directorate transfers to Keele University.

Adults living with children faced small increased COVID-related risks during UK’s second wave

Big data COVID-19 Infection & acute care

Close monitoring and evaluation as schools reopen crucial to inform ongoing policy

Load More

Sign-up for our newsletters

Contact our communications team

Our research media coverage

Our COVID-19 media coverage

 

Opinions expressed are those of the authors and not of Oxford University. Readers' comments will be moderated - see our guidelines for further information.